Epigenetic marks and their relationship with BDNF in the brain of suicide victims.

Paulina Misztak, Patrycja Pańczyszyn-Trzewik, Gabriel Nowak, Magdalena Sowa-Kućma
Author Information
  1. Paulina Misztak: Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
  2. Patrycja Pańczyszyn-Trzewik: Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
  3. Gabriel Nowak: Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.
  4. Magdalena Sowa-Kućma: Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland. ORCID

Abstract

BACKGROUND: Suicide is a common phenomenon affecting people of all ages. There is a strong relationship between suicidal ideation and depressive disorders. Increasing number of studies suggest that epigenetic modifications in certain brain areas are the main mechanism through which environmental and genetic factors interact with each other contributing to the development of mental disorders. To verify this hypothesis, some epigenetic marks: H3K9/14ac, HDAC2/3, H3K27me2 and Sin3a, as well as p-S421-MeCP2/MeCP2 were examined. On the other hand, BDNF protein level were studied.
MATERIALS AND METHODS: Western blot analysis were performed in the frontal cortex (FCx) and hippocampus (HP) of suicide victims (n = 14) and non-suicidal controls (n = 8). The differences between groups and correlations between selected proteins were evaluated using Mann-Whitney U-test and Spearman's rank correlation.
RESULTS: Statistically significant decrease in H3K9/14ac (FCx:↓~23%;HP:↓~33%) combined with increase in HDAC3 (FCx:↑~103%;HP:↑~85% in HP) protein levels in suicides compared to the controls was shown. These alterations were accompanied by an increase in H3K27me2 (FCx:↑45%;HP:↑~59%) and Sin3a (HP:↑50%) levels and decrease in p-S421-MeCP2/MeCP2 protein ratio (HP:↓~55%;FCx:↓~27%). Moreover, reduced BDNF protein level (FCx:↓~43%;HP:↓~28%) in suicides was observed. On the other hand, some significant correlations (e.g. between H3K9/14ac and HDAC2 or between BDNF and p-S421-MeCP2/MeCP2) were demonstrated.
CONCLUSIONS: Our findings confirm the role of epigenetic component and BDNF protein in suicidal behavior. Lowered BDNF protein level in suicides is probably due to decrease in histone acetylation and increased level of factors related with deacetylation and methylation processes, including MeCP2 factor, which may operate bidirectionally (an activator or inhibitor of transcription).

References

  1. J Neurosci. 2009 Sep 16;29(37):11451-60 [PMID: 19759294]
  2. Future Neurol. 2013 Jan 1;8(1): [PMID: 24348096]
  3. J Biol Chem. 2017 Sep 1;292(35):14456-14472 [PMID: 28717009]
  4. J Affect Disord. 2010 Sep;125(1-3):369-73 [PMID: 20207421]
  5. Brain Res Mol Brain Res. 2005 May 20;136(1-2):29-37 [PMID: 15893584]
  6. J Psychiatr Res. 2017 Nov;94:208-217 [PMID: 28756290]
  7. Nat Neurosci. 2009 Mar;12(3):342-8 [PMID: 19234457]
  8. Mol Psychiatry. 2017 Oct;22(10):1395-1412 [PMID: 28696430]
  9. Eur J Neurosci. 2008 May;27(10):2701-13 [PMID: 18513320]
  10. Psychoneuroendocrinology. 2007 Aug;32 Suppl 1:S21-5 [PMID: 17644269]
  11. Neuroscience. 2011 Feb 3;174:104-14 [PMID: 21056634]
  12. Int J Neuropsychopharmacol. 2018 Jun 1;21(6):528-538 [PMID: 29432620]
  13. Neuropsychopharmacology. 2013 Jan;38(1):124-37 [PMID: 22692567]
  14. Science. 2008 May 30;320(5880):1224-9 [PMID: 18511691]
  15. J Oral Sci. 2019 Nov 27;61(4):516-520 [PMID: 31631095]
  16. J Psychiatr Res. 2016 Dec;83:220-229 [PMID: 27661418]
  17. Biol Chem. 2013 Dec;394(12):1595-605 [PMID: 23912219]
  18. J Affect Disord. 2019 Jun 15;253:419-425 [PMID: 31103807]
  19. Am J Psychiatry. 2012 Nov;169(11):1194-202 [PMID: 23128924]
  20. Asian J Psychiatr. 2014 Dec;12:7-16 [PMID: 25277330]
  21. Brain Behav. 2017 Apr 19;7(6):e00706 [PMID: 28638711]
  22. Arch Gen Psychiatry. 2012 Jul;69(7):722-31 [PMID: 22752237]
  23. Neuron. 2011 Oct 6;72(1):72-85 [PMID: 21982370]
  24. Neuroscience. 2018 Jan 15;369:212-221 [PMID: 29155278]
  25. Am J Psychiatry. 2019 Aug 1;176(8):651-660 [PMID: 31164008]
  26. Exp Biol Med (Maywood). 2014 Mar;239(3):330-6 [PMID: 24495952]
  27. J Neurosci. 2013 Apr 10;33(15):6401-11 [PMID: 23575838]
  28. Cytogenet Genome Res. 2015;146(1):19-27 [PMID: 26160260]
  29. Horm Behav. 2011 Mar;59(3):331-7 [PMID: 20851702]
  30. Neuron. 2011 Aug 25;71(4):656-70 [PMID: 21867882]
  31. Neuropharmacology. 2016 Mar;102:72-9 [PMID: 26519901]
  32. J Affect Disord. 2019 Feb 15;245:152-162 [PMID: 30390504]
  33. Syst Rev. 2015 Dec 30;4:187 [PMID: 26718989]
  34. Clin Epigenetics. 2016 May 21;8:58 [PMID: 27213019]
  35. EBioMedicine. 2019 Mar;41:517-525 [PMID: 30745170]
  36. Stress. 2011 Sep;14(5):481-97 [PMID: 21848436]
  37. Biol Psychiatry. 2008 Oct 15;64(8):645-52 [PMID: 18639864]
  38. Front Psychiatry. 2018 Jan 17;8:308 [PMID: 29387021]
  39. Acta Psychiatr Scand. 2018 Apr;137(4):287-295 [PMID: 29238963]
  40. J Neural Transm (Vienna). 2008 Dec;115(12):1621-8 [PMID: 18766297]
  41. Pharmacol Rep. 2011;63(2):537-43 [PMID: 21602609]
  42. Biol Psychiatry. 2012 Apr 1;71(7):618-26 [PMID: 22265241]
  43. PLoS One. 2017 Nov 16;12(11):e0187632 [PMID: 29145409]
  44. J Affect Disord. 2013 Dec;151(3):924-31 [PMID: 24055117]
  45. J Psychiatr Res. 2013 Mar;47(3):384-90 [PMID: 23260340]
  46. J Affect Disord. 2018 Feb;227:226-235 [PMID: 29102837]
  47. Neurosci Lett. 2011 Apr 15;493(3):122-6 [PMID: 21335060]
  48. Neuropsychopharmacology. 2012 Jan;37(2):321-37 [PMID: 21956448]
  49. Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9840-5 [PMID: 24958871]
  50. Int J Mol Sci. 2017 Mar 06;18(3): [PMID: 28272318]
  51. Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 1):2375-97 [PMID: 23886513]
  52. Asian J Psychiatr. 2018 Mar;33:128-132 [PMID: 29525506]
  53. Transl Psychiatry. 2020 Feb 19;10(1):69 [PMID: 32075955]
  54. Arch Gen Psychiatry. 2009 Jan;66(1):22-32 [PMID: 19124685]
  55. Am J Med Genet B Neuropsychiatr Genet. 2018 Mar;177(2):143-167 [PMID: 29243873]
  56. Pharmacol Rep. 2018 Apr;70(2):398-408 [PMID: 29456074]
  57. Neuropsychobiology. 2016;73(1):10-5 [PMID: 26812280]
  58. Transl Psychiatry. 2017 Jan 3;7(1):e989 [PMID: 28045465]
  59. Int J Mol Sci. 2016 Aug 05;17(8): [PMID: 27527165]
  60. J Neurosci. 2004 Jun 16;24(24):5603-10 [PMID: 15201333]
  61. Rev Neurosci. 2017 Jul 26;28(6):675-692 [PMID: 28593903]
  62. Neuron. 2008 Sep 25;59(6):846-60 [PMID: 18817726]
  63. Nat Neurosci. 2006 Apr;9(4):519-25 [PMID: 16501568]
  64. Int J Neuropsychopharmacol. 2011 Jun;14(5):595-605 [PMID: 21208503]
  65. Neurosci Biobehav Rev. 2017 Jan;72:10-27 [PMID: 27836463]
  66. Neuropsychopharmacology. 2019 Nov;44(12):2119-2124 [PMID: 31476763]
  67. Int J Epidemiol. 2015 Aug;44(4):1364-87 [PMID: 25716985]
  68. Mol Psychiatry. 2012 Nov;17(11):1130-42 [PMID: 21912391]
  69. Epigenetics. 2014 Aug;9(8):1061-70 [PMID: 24802768]
  70. J Neurosci. 2012 Oct 10;32(41):14355-63 [PMID: 23055506]
  71. J Psychiatr Res. 2010 Apr;44(5):263-70 [PMID: 19767015]
  72. Clin Med Insights Pathol. 2013 Aug 26;6:1-11 [PMID: 24031163]
  73. Neuropharmacology. 2014 Jan;76 Pt C:709-18 [PMID: 23587647]
  74. Epigenetics. 2016;11(2):150-62 [PMID: 26890656]
  75. Nat Rev Neurosci. 2014 Dec;15(12):802-16 [PMID: 25354482]

MeSH Term

Adolescent
Adult
Brain-Derived Neurotrophic Factor
Case-Control Studies
Epigenesis, Genetic
Frontal Lobe
Hippocampus
Histone Deacetylases
Histones
Humans
Methyl-CpG-Binding Protein 2
Middle Aged
Sin3 Histone Deacetylase and Corepressor Complex
Suicide
Young Adult

Chemicals

Brain-Derived Neurotrophic Factor
Histones
Methyl-CpG-Binding Protein 2
SIN3A transcription factor
Histone Deacetylases
Sin3 Histone Deacetylase and Corepressor Complex
histone deacetylase 3

Word Cloud

Created with Highcharts 10.0.0BDNFproteinlevelepigeneticH3K9/14acp-S421-MeCP2/MeCP2decreasesuicidesrelationshipsuicidaldisordersbrainfactorsH3K27me2Sin3ahandHPsuicidevictimsn=controlscorrelationssignificantincreaselevelsBACKGROUND:SuicidecommonphenomenonaffectingpeopleagesstrongideationdepressiveIncreasingnumberstudiessuggestmodificationscertainareasmainmechanismenvironmentalgeneticinteractcontributingdevelopmentmentalverifyhypothesismarks:HDAC2/3wellexaminedstudiedMATERIALSANDMETHODS:WesternblotanalysisperformedfrontalcortexFCxhippocampus14non-suicidal8differencesgroupsselectedproteinsevaluatedusingMann-WhitneyU-testSpearman'srankcorrelationRESULTS:StatisticallyFCx:↓~23%HP:↓~33%combinedHDAC3FCx:↑~103%HP:↑~85%comparedshownalterationsaccompaniedFCx:↑45%HP:↑~59%HP:↑50%ratioHP:↓~55%FCx:↓~27%MoreoverreducedFCx:↓~43%HP:↓~28%observedegHDAC2demonstratedCONCLUSIONS:findingsconfirmrolecomponentbehaviorLoweredprobablyduehistoneacetylationincreasedrelateddeacetylationmethylationprocessesincludingMeCP2factormayoperatebidirectionallyactivatorinhibitortranscriptionEpigeneticmarks

Similar Articles

Cited By